These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25018661)

  • 1. Carboxylesterases: Dual roles in lipid and pesticide metabolism.
    Ross MK; Streit TM; Herring KL
    J Pestic Sci; 2010; 35(3):257-264. PubMed ID: 25018661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.
    Xie S; Borazjani A; Hatfield MJ; Edwards CC; Potter PM; Ross MK
    Chem Res Toxicol; 2010 Dec; 23(12):1890-904. PubMed ID: 21049984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human carboxylesterases: a comprehensive review.
    Wang D; Zou L; Jin Q; Hou J; Ge G; Yang L
    Acta Pharm Sin B; 2018 Sep; 8(5):699-712. PubMed ID: 30245959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opossum carboxylesterases: sequences, phylogeny and evidence for CES gene duplication events predating the marsupial-eutherian common ancestor.
    Holmes RS; Chan J; Cox LA; Murphy WJ; VandeBerg JL
    BMC Evol Biol; 2008 Feb; 8():54. PubMed ID: 18289373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon.
    Crow JA; Bittles V; Herring KL; Borazjani A; Potter PM; Ross MK
    Toxicol Appl Pharmacol; 2012 Jan; 258(1):145-50. PubMed ID: 22100607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.
    Wang J; Williams ET; Bourgea J; Wong YN; Patten CJ
    Drug Metab Dispos; 2011 Aug; 39(8):1329-33. PubMed ID: 21540359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxylesterase Inhibitors: An Update.
    Zou LW; Jin Q; Wang DD; Qian QK; Hao DC; Ge GB; Yang L
    Curr Med Chem; 2018; 25(14):1627-1649. PubMed ID: 29210644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Horse carboxylesterases: evidence for six CES1 and four families of CES genes on chromosome 3.
    Holmes RS; Cox LA; Vandeberg JL
    Comp Biochem Physiol Part D Genomics Proteomics; 2009 Mar; 4(1):54-65. PubMed ID: 20403742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine Carboxylesterases: Evidence for Two CES1 and Five Families of CES Genes on Chromosome 18.
    Holmes RS; Cox LA; Vandeberg JL
    Comp Biochem Physiol Part D Genomics Proteomics; 2009 Mar; 4(1):11-20. PubMed ID: 20161341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human carboxylesterases and their role in xenobiotic and endobiotic metabolism.
    Ross MK; Crow JA
    J Biochem Mol Toxicol; 2007; 21(4):187-96. PubMed ID: 17936933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human.
    Williams ET; Bacon JA; Bender DM; Lowinger JJ; Guo WK; Ehsani ME; Wang X; Wang H; Qian YW; Ruterbories KJ; Wrighton SA; Perkins EJ
    Drug Metab Dispos; 2011 Dec; 39(12):2305-13. PubMed ID: 21918037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of the carboxylesterase phenotype in human liver.
    Ross MK; Borazjani A; Wang R; Crow JA; Xie S
    Arch Biochem Biophys; 2012 Jun; 522(1):44-56. PubMed ID: 22525521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrolytic metabolism of pyrethroids by human and other mammalian carboxylesterases.
    Ross MK; Borazjani A; Edwards CC; Potter PM
    Biochem Pharmacol; 2006 Feb; 71(5):657-69. PubMed ID: 16387282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect.
    Merali Z; Ross S; Paré G
    Drug Metabol Drug Interact; 2014; 29(3):143-51. PubMed ID: 24988246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung.
    Gabriele M; Puccini P; Lucchi M; Vizziello A; Gervasi PG; Longo V
    Biochem Pharmacol; 2018 Apr; 150():64-71. PubMed ID: 29407485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Per- and polyfluoroalkyl substances exert strong inhibition towards human carboxylesterases.
    Liu YZ; Pan LH; Bai Y; Yang K; Dong PP; Fang ZZ
    Environ Pollut; 2020 Aug; 263(Pt A):114463. PubMed ID: 32283456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology.
    Nagaoka M; Sakai Y; Nakajima M; Fukami T
    Biochem Pharmacol; 2024 May; 223():116128. PubMed ID: 38492781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of substrate specificity among human arylacetamide deacetylase and carboxylesterases.
    Fukami T; Kariya M; Kurokawa T; Iida A; Nakajima M
    Eur J Pharm Sci; 2015 Oct; 78():47-53. PubMed ID: 26164127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation Capacity of Carboxylesterase in Skin and Keratinocytes for the Penta-Ethyl Ester Prodrug of DTPA.
    Fu J; Sadgrove M; Marson L; Jay M
    Drug Metab Dispos; 2016 Aug; 44(8):1313-8. PubMed ID: 27130352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the inhibitory effects of pyrethroids against human carboxylesterases.
    Lei W; Wang DD; Dou TY; Hou J; Feng L; Yin H; Luo Q; Sun J; Ge GB; Yang L
    Toxicol Appl Pharmacol; 2017 Apr; 321():48-56. PubMed ID: 28242322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.